Axsome Therapeutics, Inc. (AXSM) Presents at Leerink Global Healthcare Conference 2026 Transcript

Company Performance - Auvelity ended the previous year with annualized revenue just above $600 million, marking its third full year since launch in 2022, indicating strong performance in the market [1] - The company is outpacing peers in the industry, reflecting effective marketing strategies and execution [1] Sales Force and Market Access - The sales force has expanded from 160 to 260 in 2024, and further to 300 in 2025, which is expected to enhance market penetration [1] - Current market access coverage stands at 86%, showing improvement over time and contributing to revenue growth [1]